Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$27.78 -0.4%	$30.30	$26.25 ▼ $40.49	$14.25B	0.61	4.34 million shs	3.77 million shs
BSX Boston Scientific	$103.68 -0.9%	$103.42	$71.88 ▼ $107.53	$153.33B	0.68	6.75 million shs	8.57 million shs
DHR Danaher	$189.98 -2.5%	$196.13	$171.00 ▼ $281.70	$136.01B	0.77	3.52 million shs	4.24 million shs
GE GE Aerospace	$263.49 +1.2%	$244.37	$150.20 ▼ $272.80	$280.75B	1.37	5.65 million shs	8.61 million shs
ISRG Intuitive Surgical	$518.62 +0.5%	$535.90	$425.00 ▼ $616.00	$185.88B	1.64	1.67 million shs	1.90 million shs
SHL Source Energy Services		C$0.00	C$0.00 ▼ C$0.00	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$93.18 -1.8%	$93.26	$89.22 ▼ $116.71	$18.44B	0.71	1.83 million shs	1.31 million shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	0.00%	-3.24%	-6.86%	-3.89%	-22.21%
BSX Boston Scientific	0.00%	+0.50%	+2.29%	+9.05%	+33.92%
DHR Danaher	0.00%	-7.24%	-2.25%	+1.75%	-24.39%
GE GE Aerospace	0.00%	+3.13%	+11.73%	+44.87%	+68.15%
ISRG Intuitive Surgical	0.00%	+1.28%	+1.79%	+7.43%	+21.68%
ZBH Zimmer Biomet	0.00%	-0.75%	+2.99%	-4.82%	-16.09%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAX Baxter International	4.6079 of 5 stars	3.2	2.0	1.7	4.0	2.0	1.7	2.5
BSX Boston Scientific	4.684 of 5 stars	3.6	3.0	0.0	4.2	3.9	2.5	1.3
DHR Danaher	4.9662 of 5 stars	4.4	3.0	1.7	4.3	4.1	3.3	1.3
GE GE Aerospace	4.5618 of 5 stars	2.5	3.0	1.7	2.8	3.3	2.5	2.5
ISRG Intuitive Surgical	4.6393 of 5 stars	3.4	3.0	0.0	4.0	2.9	2.5	1.9
SHL Source Energy Services	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	4.9632 of 5 stars	3.2	5.0	2.5	3.7	3.8	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAX Baxter International	2.44	Hold	$36.38	30.94% Upside
BSX Boston Scientific	3.13	Buy	$116.09	11.97% Upside
DHR Danaher	2.85	Moderate Buy	$248.48	30.79% Upside
GE GE Aerospace	2.91	Moderate Buy	$240.33	-8.79% Downside
ISRG Intuitive Surgical	2.70	Moderate Buy	$592.86	14.32% Upside
SHL Source Energy Services	2.00	Hold	N/A	N/A
ZBH Zimmer Biomet	2.35	Hold	$111.39	19.54% Upside

Current Analyst Ratings Breakdown

Latest ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/18/2025	DHR Danaher	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$225.00 ➝ $226.00
7/18/2025	GE GE Aerospace	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$300.00 ➝ $321.00
7/18/2025	GE GE Aerospace	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$275.00 ➝ $300.00
7/15/2025	BAX Baxter International	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$28.00 ➝ $27.00
7/15/2025	ZBH Zimmer Biomet	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$135.00
7/14/2025	ISRG Intuitive Surgical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$566.00
7/14/2025	GE GE Aerospace	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$227.00 ➝ $296.00
7/11/2025	DHR Danaher	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Sector Outperform	$275.00
7/9/2025	BAX Baxter International	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$34.00 ➝ $32.00
7/8/2025	BAX Baxter International	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$44.00 ➝ $42.00
7/8/2025	DHR Danaher	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$230.00 ➝ $226.00

(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAX Baxter International	$10.64B	1.34	$4.76 per share	5.84	$13.76 per share	2.02
BSX Boston Scientific	$16.75B	9.16	$3.65 per share	28.39	$14.93 per share	6.94
DHR Danaher	$23.88B	5.69	$10.92 per share	17.40	$68.60 per share	2.77
GE GE Aerospace	$41.61B	6.75	$5.80 per share	45.44	$18.14 per share	14.53
ISRG Intuitive Surgical	$8.71B	21.33	$7.99 per share	64.92	$46.41 per share	11.17
SHL Source Energy Services	N/A	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$7.68B	2.40	$13.20 per share	7.06	$62.67 per share	1.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAX Baxter International	-$649M	-$1.10	N/A	10.18	0.82	-4.71%	17.24%	5.12%	7/31/2025 (Estimated)
BSX Boston Scientific	$1.85B	$1.37	75.68	32.10	2.69	11.58%	18.67%	10.38%	7/23/2025 (Estimated)
DHR Danaher	$3.90B	$5.15	36.89	22.17	2.67	15.81%	10.80%	6.89%	7/22/2025 (Estimated)
GE GE Aerospace	$6.56B	$7.17	36.75	40.79	3.09	18.64%	31.32%	4.86%	N/A
ISRG Intuitive Surgical	$2.32B	$6.82	76.04	67.97	5.50	28.41%	14.43%	12.81%	7/22/2025 (Estimated)
SHL Source Energy Services	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$903.70M	$4.52	20.62	10.51	2.15	11.86%	12.73%	7.34%	8/7/2025 (Estimated)

Latest ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	ZBH Zimmer Biomet	$1.99	N/A	N/A	N/A	$2.06 billion	N/A
7/31/2025	Q2 2025	BAX Baxter International	$0.60	N/A	N/A	N/A	$2.82 billion	N/A
7/23/2025	Q2 2025	BSX Boston Scientific	$0.72	N/A	N/A	N/A	$4.89 billion	N/A
7/22/2025	Q2 2025	DHR Danaher	$1.64	N/A	N/A	N/A	$5.83 billion	N/A
7/22/2025	Q2 2025	ISRG Intuitive Surgical	$1.92	N/A	N/A	N/A	$2.35 billion	N/A
7/17/2025	Q2 2025	GE GE Aerospace	$1.43	$1.66	+$0.23	$1.89	$9.49 billion	$10.15 billion
5/5/2025	Q1 2025	ZBH Zimmer Biomet	$1.77	$1.81	+$0.04	$0.91	$1.89 billion	$1.91 billion
5/1/2025	Q1 2025	BAX Baxter International	$0.48	$0.62	+$0.14	$0.25	$2.59 billion	$2.63 billion
4/23/2025	Q1 2025	BSX Boston Scientific	$0.67	$0.75	+$0.08	$0.45	$4.57 billion	$4.66 billion
4/22/2025	Q1 2025	DHR Danaher	$1.62	$1.88	+$0.26	$1.32	$5.58 billion	$5.74 billion
4/22/2025	Q1 2025	GE GE Aerospace	$1.29	$1.49	+$0.20	$1.83	$9.06 billion	$9.94 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAX Baxter International	$0.68	2.45%	N/A	N/A	N/A
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
DHR Danaher	$1.28	0.67%	N/A	24.85%	2 Years
GE GE Aerospace	$1.44	0.55%	N/A	20.08%	2 Years
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
SHL Source Energy Services	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$0.96	1.03%	N/A	21.24%	N/A

Latest ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/14/2025	BAX Baxter International	quarterly	$0.17	2.38%	8/29/2025	8/29/2025	10/1/2025
5/30/2025	ZBH Zimmer Biomet	quarterly	$0.24	1.03%	6/26/2025	6/26/2025	7/31/2025
5/6/2025	DHR Danaher	quarterly	$0.32	0.67%		6/27/2025	7/25/2025
6/27/2025	GE GE Aerospace	quarterly	$0.36	0.56%		7/7/2025	7/25/2025
5/6/2025	BAX Baxter International	quarterly	$0.17	2.27%	5/30/2025	5/30/2025	7/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAX Baxter International	1.33	2.02	1.40
BSX Boston Scientific	0.47	1.45	0.88
DHR Danaher	0.31	1.43	1.05
GE GE Aerospace	0.88	1.04	0.77
ISRG Intuitive Surgical	N/A	4.98	3.97
SHL Source Energy Services	N/A	N/A	N/A
ZBH Zimmer Biomet	0.53	2.44	1.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAX Baxter International	90.19%
BSX Boston Scientific	89.07%
DHR Danaher	79.05%
GE GE Aerospace	74.77%
ISRG Intuitive Surgical	83.64%
SHL Source Energy Services	N/A
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
BAX Baxter International	0.21%
BSX Boston Scientific	0.50%
DHR Danaher	11.10%
GE GE Aerospace	0.21%
ISRG Intuitive Surgical	0.70%
SHL Source Energy Services	N/A
ZBH Zimmer Biomet	1.39%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAX Baxter International	38,000	513.17 million	512.10 million	Optionable
BSX Boston Scientific	53,000	1.48 billion	1.47 billion	Optionable
DHR Danaher	63,000	715.67 million	636.23 million	Optionable
GE GE Aerospace	53,000	1.07 billion	1.06 billion	Optionable
ISRG Intuitive Surgical	15,638	358.42 million	355.91 million	Optionable
SHL Source Energy Services	N/A	N/A	N/A	Not Optionable
ZBH Zimmer Biomet	17,000	197.85 million	195.10 million	Optionable

ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Headlines

Recent News About These Companies

SMH physicians use hand-held robots for knee replacement surgeries

July 20 at 6:23 AM | msn.com

AMG National Trust Bank Increases Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 19 at 8:46 AM | marketbeat.com

Zimmer Biomet to pay $177M for orthopedic robotics company

July 18 at 1:15 PM | beckershospitalreview.comB

Cerity Partners LLC Cuts Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 18 at 3:50 AM | marketbeat.com

Zimmer Biomet (NYSE:ZBH) Upgraded at Roth Capital

July 18 at 2:53 AM | americanbankingnews.com

ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal

July 17 at 10:51 AM | zacks.com

Roth MKM upgrades Zimmer Biomet Holdings (ZBH) to a Buy

July 17 at 8:13 AM | theglobeandmail.com

What You Need To Know Ahead of Zimmer Biomet's Earnings Release

July 17 at 8:13 AM | msn.com

MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM

July 16, 2025 | businesswire.com

Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH)

July 16, 2025 | insidermonkey.com

Equity Investment Corp Acquires 17,286 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 16, 2025 | marketbeat.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sarepta Therapeutics (SRPT), Zimmer Biomet Holdings (ZBH) and Eli Lilly & Co (LLY)

July 16, 2025 | theglobeandmail.com

New York State Common Retirement Fund Grows Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 16, 2025 | marketbeat.com

Zimmer Biomet enters agreement to acquire orthopaedic robotics company, Monogram Technologies

July 15, 2025 | pharmabiz.comP

Zimmer Biomet inks $177M deal for Monogram and its hands-free orthopedic robot

July 15, 2025 | fiercebiotech.comF

Zimmer Biomet wins price target raise at Roth

July 15, 2025 | cantechletter.comC

Zimmer upgraded to Buy at Roth Capital on Monogram deal

July 15, 2025 | msn.com

Bryn Mawr Capital Management LLC Boosts Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 15, 2025 | marketbeat.com

Zimmer Biomet (NYSE:ZBH) Raised to Buy at Roth Capital

July 15, 2025 | marketbeat.com

Zimmer to acquire Monogram Technologies for $177 million, boosting robotics portfolio

July 14, 2025 | msn.com

Zimmer Biomet acquisition of Monogram Technologies to expand capacity in robotics devices

July 14, 2025 | journalgazette.netJ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
3 Semiconductor Stocks Poised to Surge on AI Spending
By Chris Markoch | June 25, 2025
View 3 Semiconductor Stocks Poised to Surge on AI Spending
How a Government Loan Changes the Game for Plug Power
By Jeffrey Neal Johnson | July 4, 2025
View How a Government Loan Changes the Game for Plug Power
BigBear.ai: Why a 90% Rally Could Be Just the Start
By Jeffrey Neal Johnson | July 10, 2025
View BigBear.ai: Why a 90% Rally Could Be Just the Start

ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Company Descriptions

Baxter International NYSE:BAX

$27.78 -0.11 (-0.39%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$27.80 +0.02 (+0.07%)

As of 07/18/2025 06:56 PM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Boston Scientific NYSE:BSX

$103.68 -0.97 (-0.93%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$103.63 -0.05 (-0.05%)

As of 07/18/2025 08:00 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Danaher NYSE:DHR

$189.98 -4.81 (-2.47%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$189.76 -0.22 (-0.11%)

As of 07/18/2025 07:59 PM Eastern

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

GE Aerospace NYSE:GE

$263.49 +3.21 (+1.23%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$263.38 -0.12 (-0.04%)

As of 07/18/2025 07:59 PM Eastern

GE Aerospace (also known as General Electric) is a company that specializes in providing aerospace products and services. It operates through two reportable segments: Commercial Engines and Services and Defense and Propulsion Technologies. It offers jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. GE demerged into GE Vernova, GE Aerospace, and GE Healthcare.

Intuitive Surgical NASDAQ:ISRG

$518.62 +2.46 (+0.48%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$518.85 +0.23 (+0.04%)

As of 07/18/2025 07:55 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Source Energy Services TSE:SHL

Homeland Nickel Inc. is a mineral exploration company. It is focused on critical metal resources with nickel projects in Oregon, United States and copper projects in Newfoundland, Canada. Its projects include Cleopatra, Red Flat Nickel Property, Shamrock Property, and Eight Dollar Mountain. The Cleopatra property is located in southwest Oregon and consists of 139 lode mining claims covering a total area of 1,162 hectares (2,872 acres). The Red Flat Nickel property is located in southwest Oregon 15 kilometers (km) east of Gold Beach and 480 km south of the City of Portland. The Eight Dollar Mountain property is located in Josephine County, Oregon. The Eight Dollar Mountain property consists of 115 claims totaling 962 hectares (2,376 acres). The Shamrock Property consists of 40 unpatented load claims, accessible by paved road, covering 758 acres and located 20 miles northwest of Medford, Oregon. It also owns a 70% interest in the Great Burnt and South Pond copper and gold properties.

Zimmer Biomet NYSE:ZBH

$93.18 -1.72 (-1.81%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$93.90 +0.72 (+0.78%)

As of 07/18/2025 07:57 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Earnings

Compare Dividends

Latest ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ZBH, DHR, BAX, SHL, GE, ISRG, and BSX Company Descriptions

Baxter International NYSE:BAX

Boston Scientific NYSE:BSX

Danaher NYSE:DHR

GE Aerospace NYSE:GE

Intuitive Surgical NASDAQ:ISRG

Source Energy Services TSE:SHL

Zimmer Biomet NYSE:ZBH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools